Search for: "Novartis Corporation "
Results 161 - 180
of 312
Sorted by Relevance
|
Sort by Date
27 Mar 2012, 12:58 pm
Novartis case from New Jersey. [read post]
25 Aug 2010, 7:37 am
The drug is manufactured by Finnish drugmaker Orion Corporation and is marked by Swiss-based Novartis Pharmaceuticals. [read post]
19 Jul 2010, 7:07 pm
It seems like discrimination this pervasive – essentially, discrimination as corporate policy – should be a relic of the Mad Men past. [read post]
23 Nov 2010, 2:00 pm
., $302 million from AstraZeneca, and $192.7 from Novartis Pharmaceutical Corporation. [read post]
11 Aug 2021, 12:57 pm
Sarepta Technologies SANGENTRI 90382648 Novartis AG UAMG Content, LLC BILLIONAIRE U. 90394028 Majestas Sarl Spectrum Brands, Inc. [read post]
17 Aug 2012, 10:29 am
Prior to that, her career included a variety of legal positions with Chiron Corporation and Novartis Vaccines and Diagnostics, Inc., and a partnership at the Farella, Braun & Martel law firm in San Francisco. [read post]
1 Jul 2010, 1:32 pm
Novartis Pfizer Sanofi-Aventis Takeda Pharmaceuticals [read post]
22 Jul 2010, 8:35 am
Ian Bryan, IP Counsel, GE Healthcare Vineet Kohli, Senior Patent Attorney, Merck John Beatty, Patent Procedures Management, European Patent Office Dr Roman Maksymiw, Head of Division, German Patent and Trademark Office, DPMA Lawrence Cullen, Deputy Director, IPO Dr Scott Alban, Head of IP, MedImmune Allen Norris, Vice President, Head Group IP, UCB Pharma SA Peter Thomsen, Manager Global IP Litigation and Global Policy, Novartis International AG Morten Rosted,… [read post]
23 Feb 2010, 2:05 pm
It can provide tremendous insight to the corporate operations even if nothing material as a compliance issues comes from the hotline. [read post]
26 Oct 2007, 2:03 am
Court of Appeal (Civil Division) Neil Martin Ltd v HM Revenue & Customs [2007] EWCA Civ 1041 (25 October 2007) Cadogan & Anor v Sportelli & Anor [2007] EWCA Civ 1042 (25 October 2007) Boudh v Bodh [2007] EWCA Civ 1019 (25 October 2007) AA (Somalia) v SSHD [2007] EWCA Civ 1040 (25 October 2007) Kohn v Wagschal & Ors [2007] EWCA Civ 1022 (24 October 2007) Poole & Ors v HM Treasury [2007] EWCA Civ 1021 (24 October 2007) Wright & Ors, R (on the… [read post]
1 Nov 2010, 12:17 pm
This was the argument made by the Cintas Corporation, a company that supplies uniforms to businesses. [read post]
13 Mar 2023, 6:00 am
Novartis Corp. in 2010), verdicts in New York State courts were lower. [read post]
27 Jul 2011, 1:01 am
Highlights this week included: Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of equivalents: Duramed Pharmaceuticals, Inc. v. [read post]
15 Apr 2010, 4:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: CAFC denies Vanderbilt’s claim to Cialis patent right: Vanderbilt University v ICOS Corporation (Patently-O) (IPBiz) Paris District Court: Basic patent for Losartan covers any product comprising Losartan: Du Pont v Mylan Losartan SPC case (EPLAW) General WHO documents from counterfeit meeting now online (IP… [read post]
18 Apr 2014, 11:00 am
Ciba-Geigy Corporation, 78 F.3d 316, 319 (7th Cir. 1996). [read post]
27 Aug 2011, 7:55 pm
This is "the sport of kings," that only large corporations can play. [read post]
13 Aug 2020, 12:38 pm
On June 25, 2020, the SEC announced settlement with drug company Novartis AG and its subsidiary Alcon Pte Ltd related to payments made by third parties in Asia and Europe to get doctors (including at state-owned hospitals) to prescribe Novartis drugs. [read post]
22 Jul 2010, 10:11 am
This case is distinguishable from Novartis Vaccines & Diagnostics, Inc. v. [read post]
25 Apr 2013, 4:24 am
Sodexo tops the list for 2013, followed by PricewaterhouseCoopers, Kaiser Permanente, Ernst & Young, MasterCard Worldwide, Novartis Pharmaceuticals Corporation, Procter & Gamble, Prudential Financial, Accenture and Johnson & Johnson. [read post]
12 Feb 2010, 6:55 am
“If this science and innovation can’t be patented, it is sending a very strong message about how limited India’s patent protections are,” says Gregg Alton, executive vice-president of corporate and medical affairs at Gilead Sciences. [read post]
